Literature DB >> 30012870

Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Lucie S Meyer1, Xiao Wang, Eva Sušnik1, Jacopo Burrello2, Alessio Burrello3, Isabella Castellano4, Graeme Eisenhofer5,6, Francesco Fallo7, Gregory A Kline8, Thomas Knösel9, Tomaz Kocjan10, Jacques W M Lenders6,11, Paolo Mulatero2, Mitsuhide Naruse12, Tetsuo Nishikawa13, Mirko Peitzsch5, Lars C Rump14, Felix Beuschlein1,15, Stefanie Hahner16, Celso E Gomez-Sanchez17,18, Martin Reincke1, Tracy Ann Williams1,2.   

Abstract

Unilateral primary aldosteronism (PA) is the most common surgically curable form of hypertension that must be accurately differentiated from bilateral PA for therapeutic management (surgical versus medical). Adrenalectomy results in biochemical cure (complete biochemical success) in almost all patients diagnosed with unilateral PA; the remaining patients with partial or absent biochemical success comprise those with persisting aldosteronism who were misdiagnosed as unilateral PA preoperatively. To identify determinants of postsurgical biochemical outcomes, we compared the adrenal histopathology and the peripheral venous steroid profiles of patients with partial and absent or complete biochemical success after adrenalectomy for unilateral PA. A large multicenter cohort of adrenals from patients with absent and partial biochemical success (n=43) displayed a higher prevalence of hyperplasia (49% versus 21%; P=0.004) and a lower prevalence of solitary functional adenoma (44% versus 79%; P<0.001) compared with adrenals from age- and sex-matched patients with PA with complete biochemical success (n=52). We measured the peripheral plasma steroid concentrations in a subgroup of these patients (n=43) and in a group of patients with bilateral PA (n=27). Steroid profiling was associated with histopathologic phenotypes (solitary functional adenoma, hyperplasia, and aldosterone-producing cell clusters) and classified patients according to biochemical outcome or diagnosis of bilateral PA. If validated, peripheral venous steroid profiling may be a useful tool to guide the decision to perform surgery based on expectations of biochemical outcome after the procedure.

Entities:  

Keywords:  adrenal glands; adrenalectomy; aldosterone; hyperaldosteronism; immunohistochemistry

Mesh:

Substances:

Year:  2018        PMID: 30012870      PMCID: PMC6202235          DOI: 10.1161/HYPERTENSIONAHA.118.11465

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

1.  Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Authors:  T Dekkers; M ter Meer; J W M Lenders; A R M Hermus; L Schultze Kool; J F Langenhuijsen; K Nishimoto; T Ogishima; K Mukai; E A B Azizan; B Tops; J Deinum; B Küsters
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

2.  Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.

Authors:  Britta Heinze; Carmina T Fuss; Paolo Mulatero; Felix Beuschlein; Martin Reincke; Mona Mustafa; Andreas Schirbel; Timo Deutschbein; Tracy Ann Williams; Yara Rhayem; Marcus Quinkler; Nada Rayes; Silvia Monticone; Vanessa Wild; Celso E Gomez-Sanchez; Anna-Carinna Reis; Stephan Petersenn; Hans-Juergen Wester; Saskia Kropf; Martin Fassnacht; Katharina Lang; Ken Herrmann; Andreas K Buck; Christina Bluemel; Stefanie Hahner
Journal:  Hypertension       Date:  2017-12-26       Impact factor: 10.190

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

4.  Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.

Authors:  Timothy J Burton; Isla S Mackenzie; Kottekkattu Balan; Brendan Koo; Nick Bird; Dmitri V Soloviev; Elena A B Azizan; Franklin Aigbirhio; Mark Gurnell; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

5.  Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.

Authors:  Graeme Eisenhofer; Tanja Dekkers; Mirko Peitzsch; Anna S Dietz; Martin Bidlingmaier; Marcus Treitl; Tracy A Williams; Stefan R Bornstein; Matthias Haase; L C Rump; Holger S Willenberg; Felix Beuschlein; Jaap Deinum; Jacques W M Lenders; Martin Reincke
Journal:  Clin Chem       Date:  2016-01-19       Impact factor: 8.327

6.  Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism.

Authors:  Fumitoshi Satoh; Ryo Morimoto; Yoshikiyo Ono; Yoshitsugu Iwakura; Kei Omata; Masataka Kudo; Kei Takase; Kazumasa Seiji; Hidehiko Sasamoto; Seijiro Honma; Mitsunobu Okuyama; Kouwa Yamashita; Celso E Gomez-Sanchez; William E Rainey; Yoichi Arai; Hironobu Sasano; Yasuhiro Nakamura; Sadayoshi Ito
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

Review 7.  Systematic review of surgery and outcomes in patients with primary aldosteronism.

Authors:  A Muth; O Ragnarsson; G Johannsson; B Wängberg
Journal:  Br J Surg       Date:  2015-01-20       Impact factor: 6.939

Review 8.  Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.

Authors:  Koshiro Nishimoto; Minae Koga; Tsugio Seki; Kenji Oki; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Mitsuhide Naruse; Tomokazu Sakaguchi; Shinya Morita; Takeo Kosaka; Mototsugu Oya; Tadashi Ogishima; Masanori Yasuda; Makoto Suematsu; Yasuaki Kabe; Masao Omura; Tetsuo Nishikawa; Kuniaki Mukai
Journal:  Mol Cell Endocrinol       Date:  2016-10-14       Impact factor: 4.102

9.  Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Riccardo Boetto; Italo Bonadio; Saveria Tropea; Franco Mantero; Gian Paolo Rossi; Ambrogio Fassina; Donato Nitti; Gennaro Favia
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

10.  Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.

Authors:  Tobias Åkerström; Joakim Crona; Alberto Delgado Verdugo; Lee F Starker; Kenko Cupisti; Holger S Willenberg; Wolfram T Knoefel; Wolfgang Saeger; Alfred Feller; Julian Ip; Patsy Soon; Martin Anlauf; Pier F Alesina; Kurt W Schmid; Myriam Decaussin; Pierre Levillain; Bo Wängberg; Jean-Louis Peix; Bruce Robinson; Jan Zedenius; Martin Bäckdahl; Stefano Caramuta; K Alexander Iwen; Johan Botling; Peter Stålberg; Jean-Louis Kraimps; Henning Dralle; Per Hellman; Stan Sidhu; Gunnar Westin; Hendrik Lehnert; Martin K Walz; Göran Åkerström; Tobias Carling; Murim Choi; Richard P Lifton; Peyman Björklund
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  15 in total

1.  Visualizing Adrenal Steroids in Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Tracy A Williams
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

Review 2.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

3.  In situ metabolomics of aldosterone-producing adenomas.

Authors:  Masanori Murakami; Yara Rhayem; Thomas Kunzke; Na Sun; Annette Feuchtinger; Philippe Ludwig; Tim Matthias Strom; Celso Gomez-Sanchez; Thomas Knösel; Thomas Kirchner; Tracy Ann Williams; Martin Reincke; Axel Karl Walch; Felix Beuschlein
Journal:  JCI Insight       Date:  2019-09-05

Review 4.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 5.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

Review 6.  Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review.

Authors:  Marta Araujo-Castro; Pablo Valderrábano; Héctor F Escobar-Morreale; Felicia A Hanzu; Gregori Casals
Journal:  Endocrine       Date:  2020-11-21       Impact factor: 3.633

Review 7.  The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.

Authors:  Jung Soo Lim; William E Rainey
Journal:  Horm Metab Res       Date:  2020-03-30       Impact factor: 2.936

8.  Classification of microadenomas in patients with primary aldosteronism by steroid profiling.

Authors:  Yuhong Yang; Jacopo Burrello; Alessio Burrello; Graeme Eisenhofer; Mirko Peitzsch; Martina Tetti; Thomas Knösel; Felix Beuschlein; Jacques W M Lenders; Paolo Mulatero; Martin Reincke; Tracy Ann Williams
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-14       Impact factor: 4.292

9.  Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

Authors:  Minna Soinio; Anna-Kaarina Luukkonen; Marko Seppänen; Jukka Kemppainen; Janne Seppänen; Juha-Pekka Pienimäki; Helena Leijon; Tiina Vesterinen; Johanna Arola; Eila Lantto; Semi Helin; Ilkka Tikkanen; Saara Metso; Tuomas Mirtti; Ilkka Heiskanen; Leena Norvio; Mirja Tiikkainen; Tuula Tikkanen; Timo Sane; Matti Välimäki; Celso E Gomez-Sanchez; Ilkka Pörsti; Pirjo Nuutila; Pasi I Nevalainen; Niina Matikainen
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

10.  International Histopathology Consensus for Unilateral Primary Aldosteronism.

Authors:  Tracy Ann Williams; Celso E Gomez-Sanchez; William E Rainey; Thomas J Giordano; Alfred K Lam; Alison Marker; Ozgur Mete; Yuto Yamazaki; Maria Claudia Nogueira Zerbini; Felix Beuschlein; Fumitoshi Satoh; Jacopo Burrello; Holger Schneider; Jacques W M Lenders; Paolo Mulatero; Isabella Castellano; Thomas Knösel; Mauro Papotti; Wolfgang Saeger; Hironobu Sasano; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.